Average Co-Inventor Count = 4.10
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (22 from 2,076 patents)
22 patents:
1. 11919881 - Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors
2. 11897880 - 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
3. 11845748 - Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors
4. 11814364 - Pyridine N-oxide derivatives useful as factor XIa inhibitors
5. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
6. 11014917 - 5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
7. 10815210 - Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators
8. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
9. 10696662 - 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
10. 10251864 - Indole derivatives useful as glucagon receptor antagonists
11. 10214493 - Indazole derivatives useful as glucagon receptor antagonists
12. 10000473 - Indazole derivatives useful as glucagon receptor antagonists
13. 9238658 - Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
14. 9102669 - Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
15. 9012412 - Dual SGLT1/SGLT2 inhibitors